Pediatric idiopathic nephrotic syndrome: Treatment strategies in steroid dependent and steroid resistant forms

Current Medicinal Chemistry

Volumn 17, Issue 9, 2010, Pages 847-853

  Ulinski, T ^a   Aoun, B ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Cyclophosphamide; Cyclosporine A; Glucocortico ds; Idiopathic nephrotic syndrome; Immunosuppressive treatment; Levamisol; Mycophenolate mofetil; Nephrotoxicity; Plasma exchange; Rituximab

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INFLIXIMAB; INOSINATE DEHYDROGENASE; LEVAMISOLE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEFLOXACIN; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

AMENORRHEA; AZOOSPERMIA; CATARACT; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; FERTILITY; GINGIVA HYPERPLASIA; GINGIVA HYPERTROPHY; GROWTH RATE; HEMORRHAGIC CYSTITIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRICHOSIS; IDIOPATHIC NEPHROTIC SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; LIVER TOXICITY; MORBIDITY; NEPHROTIC SYNDROME; NEPHROTOXICITY; NEUTROPENIA; OLIGOSPERMIA; PATIENT COMPLIANCE; PLASMAPHERESIS; PROGNOSIS; PURINE SYNTHESIS; RELAPSE; REMISSION; REPRODUCTIVE TOXICITY; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STEROID THERAPY; TESTIS ATROPHY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIBODIES, MONOCLONAL; CHILD; CYCLOSPORINE; ENZYME INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEVAMISOLE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; STEROIDS; TACROLIMUS; TRIAMCINOLONE ACETONIDE;

EID: 77950657799     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790712174     Document Type: Review

References (63)

1. Hooft, C.; Van Acker, K. J. The natural history of the idiopathic nephrotic syndrome in childhood. Ann. Paediatr., 1966, 207, 1-19.
2. Kanasawa, M. Idiopathic nephrotic syndrome of childhood. A light-microscopic study of the histologic spectrum as revealed by renal biopsies. Acta Med. Biol. (Niigata)., 1967, 14, 217-251
3. Robson, A. M.; Giangiacomo, J.; Kienstra, R. A.; Naqvi, S. T.; Ingelfinger, J. R. Normal glomerular permeability and its modification by minimal change nephrotic syndrmone. J. Clin. Invest., 1974, 54, 1190-1199
4. Bagga, A.; Mantan, M. Nephrotic syndrome in children. Indian J. Med. Res., 2005, 122, 13-28.
5. Habib, R.; Kleinknecht, C. The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol. Annu., 1971, 6, 417-474
6. Lapillonne, H.; Leclerc, A.; Ulinski, T.; Balu, L.; Garnier, A.; Dereuddre-Bosquet, N.; Watier, H.; Schlageter, M. H.; Deschenes, G. Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome. Pediatr. Nephrol., 2008, 23, 1251-1256
7. Guigonis, V.; Dallocchio, A.; Baudouin, V.; Dehennault, M.; Hachon-Le Camus, C.; Afanetti, M.; Groothoff, J.; Llanas, B.; Niaudet, P.; Nivet, H.; Raynaud, N.; Taque, S.; Ronco, P.; Bouissou, F. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr. Nephrol., 2008, 23, 1269-1279
8. Eagen, J. W. Glomerulopathies of neoplasia. Kidney Int., 1977, 11, 297-303.
9. Frange, P.; Frey, M. A.; Deschenes, G. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome]. Arch. Pediatr., 2005, 12, 305-315
10. Chugh, K. S.; Malik, N.; Uberoi, H. S.; Gupta, V. K.; Aggarwal, M. L.; Singhal, P. C.; Suri, S.; Jain, S. K. Renal vein thrombosis in nephrotic syndrome - a prospective study and review. Postgrad. Med. J., 1981, 57, 566-570 (Pubitemid 11046732)
11. Bagga, A.; Ali, U.; Banerjee, S.; Kanitkar, M.; Phadke, K. D.; Senguttuvan, P.; Sethi, S.; Shah, M. Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr., 2008, 45, 203-214 (Pubitemid 351457458)
12. Habib, R.; Levy, M.; Gubler, M. C. Clinicopathologic correlations in the nephrotic syndrome. Paediatrician, 1979, 8, 325-348
13. Reusz, G.; Szabo, A.; Fekete, A. [Nephrotic syndrome in childhood]. Orv. Hetil., 2006, 147, 2251-2260
14. Melvin, T.; Bennett, W. Management of nephrotic syndrome in childhood. Drugs, 1991, 42, 30-51.
15. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft fur Padiatrische Nephrologie". Lancet, 1979, 1, 401-403
16. Warshaw, B. L.; Hymes, L. C. Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome. Pediatrics, 1989, 83, 694-699
17. Bagga, A.; Hari, P.; Srivastava, R. N. Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndrome. Pediatr. Nephrol., 1999, 13, 824-827
18. Robinson, J. Efficacy of pneumococcal immunization in patients with renal disease - what is the data? Am. J. Nephrol., 2004, 24, 402-409 (Pubitemid 39279381)
19. Hodson, E. The management of idiopathic nephrotic syndrome in children. Paediatr. Drugs, 2003, 5, 335-349 (Pubitemid 36629716)
20. Filler, G. Treatment of nephrotic syndrome in children and controlled trials. Nephrol. Dial Transplant, 2003, 18 Suppl 6, vi75-8.
21. Srivastava, R. N.; Vasudev, A. S.; Bagga, A. Levamisole in nephrotic syndrome. Lancet, 1991, 338, 1275.
22. Szeto, C.; Gillespie, K. M.; Mathieson, P. W. Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology, 2000, 100, 217-224
23. Tanphaichitr, P.; Tanphaichitr, D.; Sureeratanan, J.; Chatasingh, S. Treatment of nephrotic syndrome with levamisole. J. Pediatr., 1980, 96, 490-493
24. Bagga, A.; Sharma, A.; Srivastava, R. N. Levamisole therapy in corticosteroid-dependent nephrotic syndrome. Pediatr. Nephrol., 1997, 11, 415-417 (Pubitemid 27322845)
25. Fulton, B.; Markham, A. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation. Drugs, 1996, 51, 278-298 (Pubitemid 26039160)
26. Afzal, K.; Bagga, A.; Menon, S.; Hari, P.; Jordan, S. C. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome. Pediatr. Nephrol., 2007, 22, 2059-2065 (Pubitemid 350090712)
27. Ulinski, T.; Dubourg, L.; Said, M. H.; Parchoux, B.; Ranchin, B.; Cochat, P. Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr. Nephrol., 2005, 20, 482-485 (Pubitemid 40392623)
28. Barletta, G. M.; Smoyer, W. E.; Bunchman, T. E.; Flynn, J. T.; Kershaw, D. B. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr. Nephrol., 2003, 18, 833-837 (Pubitemid 36949975)
29. El-Reshaid, K.; El-Reshaid, W.; Madda, J. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis. Ren. Fail., 2005, 27, 523-530 (Pubitemid 41216307)
30. Hoyer, P. F.; Krull, F.; Brodehl, J. Cyclosporin in frequently relapsing minimal change nephrotic syndrome. Lancet, 1986, 2, 335. (Pubitemid 16069625)
31. Meyrier, A.; Noel, L. H.; Auriche, P.; Callard, P. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int., 1994, 45, 1446-1456
32. Kitano, Y.; Yoshikawa, N.; Tanaka, R.; Nakamura, H.; Ninomiya, M.; Ito, H. Ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr. Nephrol., 1990, 4, 474-477 (Pubitemid 20335346)
33. Ishikura, K.; Ikeda, M.; Hattori, S.; Yoshikawa, N.; Sasaki, S.; Iijima, K.; Nakanishi, K.; Yata, N.; Honda, M. Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int., 2008, 73, 1167-1173
34. Choudhry, S.; Bagga, A.; Hari, P.; Sharma, S.; Kalaivani, M.; Dinda, A. Efficacy and Safety of Tacrolimus Versus Cyclosporine in Children With Steroid-Resistant Nephrotic Syndrome: A Randomized Controlled Trial. Am. J. Kidney Dis., 2009, 53, 760-769
35. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft fur Padiatrische Nephrologie. Arch. Dis. Child, 1987, 62, 1102-1106
36. Prasad, N.; Gulati, S.; Sharma, R. K.; Singh, U.; Ahmed, M. Pulse cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr. Nephrol., 2004, 19, 494-498 (Pubitemid 38594286)
37. Tarshish, P.; Tobin, J. N.; Bernstein, J.; Edelmann, C. M., Jr. Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the international study of kidney disease in children. Pediatr. Nephrol., 1996, 10, 590-593 (Pubitemid 126745992)
38. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the international study of kidney disease in children. Lancet, 1974, 2, 423-427
39. Mantan, M.; Sriram, C. S.; Hari, P.; Dinda, A.; Bagga, A. Efficacy of intravenous pulse cyclophosphamide treatment versus combination of intravenous dexamethasone and oral cyclophosphamide treatment in steroid-resistant nephrotic syndrome. Pediatr. Nephrol., 2008, 23, 1495-1502
40. Ulinski, T.; Perrin, L.; Guigonis, V.; Driss, F.; Deschenes, G.; Bensman, A. Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression. Pediatr. Nephrol., 2007, 22, 1723-1726 (Pubitemid 47337427)
41. Ulinski, T.; Carlier-Legris, A.; Schlecht, D.; Ranchin, B.; Cochat, P. Triamcinolone acetonide: a new management of noncompliance in nephrotic children. Pediatr. Nephrol., 2005, 20, 759-762 (Pubitemid 40663158)
42. Letavernier, B.; Letavernier, E.; Leroy, S.; Baudet-Bonneville, V.; Bensman, A.; Ulinski, T. Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome. Pediatr. Nephrol., 2008, 23, 2221-2226
43. Constantinescu, A. R.; Shah, H. B.; Foote, E. F.; Weiss, L. S. Predicting first-year relapses in children with nephrotic syndrome. Pediatrics, 2000, 105, 492-495 (Pubitemid 30129660)
44. Takeda, A.; Takimoto, H.; Mizusawa, Y.; Simoda, M. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome. Pediatr. Nephrol., 2001, 16, 888-893 (Pubitemid 33040647)
45. Fervenza, F. C.; Cosio, F. G.; Erickson, S. B.; Specks, U.; Herzenberg, A. M.; Dillon, J. J.; Leung, N.; Cohen, I. M.; Wochos, D. N.; Bergstralh, E.; Hladunewich, M.; Cattran, D. C. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int., 2008, 73, 117-125 (Pubitemid 350273646)
46. Gilbert, R. D.; Hulse, E.; Rigden, S. Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr. Nephrol., 2006, 21, 1698-1700 (Pubitemid 44390835)
47. Suri, M.; Tran, K.; Sharma, A. P.; Filler, G.; Grimmer, J. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab. Int. Urol. Nephrol., 2008, 40, 807-810
48. Nakayama, M.; Kamei, K.; Nozu, K.; Matsuoka, K.; Nakagawa, A.; Sako, M.; Iijima, K. Rituximab for refractory focal segmental glomerulosclerosis. Pediatr. Nephrol., 2008, 23, 481-485
49. Bagga, A.; Mudigoudar, B. D.; Hari, P.; Vasudev, V. Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr. Nephrol., 2004, 19, 45-50. (Pubitemid 38088249)
50. Gero, L. [Treatment of nephrotic syndrome in the adult]. Orv. Hetil., 2006, 147, 2313-2318
51. Yi, Z.; Li, Z.; Wu, X. C.; He, Q. N.; Dang, X. Q.; He, X. J. Effect of fosinopril in children with steroid-resistant idiopathic nephrotic syndrome. Pediatr. Nephrol., 2006, 21, 967-972 (Pubitemid 43885096)
52. Zivicnjak, M.; Franke, D.; Zenker, M.; Hoyer, J.; Lucke, T.; Pape, L.; Ehrich, J. H. SMARCAL1 mutations: a cause of prepubertal idiopathic steroid-resistant nephrotic syndrome. Pediatr. Res., 2009, 65, 564-568
53. Santin, S.; Garcia-Maset, R.; Ruiz, P.; Gimenez, I.; Zamora, I.; Pena, A.; Madrid, A.; Camacho, J. A.; Fraga, G.; Sanchez-Moreno, A.; Cobo, M. A.; Bernis, C.; Ortiz, A.; de Pablos, A. L.; Pintos, G.; Justa, M. L.; Hidalgo-Barquero, E.; Fernandez-Llama, P.; Ballarin, J.; Ars, E.; Torra, R. Nephrin mutations cause childhood- and adult-onset focal segmental glomerulosclerosis. Kidney Int., 2009, 76, 1268-1276
54. Otukesh, H.; Ghazanfari, B.; Fereshtehnejad, S. M.; Bakhshayesh, M.; Hashemi, M.; Hoseini, R.; Chalian, M.; Salami, A.; Mehdipor, L.; Rahiminia, A. NPHS2 mutations in children with steroid-resistant nephrotic syndrome. Iran. J. Kidney Dis., 2009, 3, 99-102.
55. Hildebrandt, F.; Heeringa, S. F. Specific podocin mutations determine age of onset of nephrotic syndrome all the way into adult life. Kidney Int., 2009, 75, 669-671
56. Lenkkeri, U.; Mannikko, M.; McCready, P.; Lamerdin, J.; Gribouval, O.; Niaudet, P. M.; Antignac, C. K.; Kashtan, C. E.; Homberg, C.; Olsen, A.; Kestila, M.; Tryggvason, K. Structure of the gene for congenital nephrotic syndrome of the finnish type (NPHS1) and characterization of mutations. Am. J. Hum. Gene., 1999, 64, 51-61. (Pubitemid 30428957)
57. Weber, S.; Gribouval, O.; Esquivel, E. L.; Moriniere, V.; Tete, M. J.; Legendre, C.; Niaudet, P.; Antignac, C. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int., 2004, 66, 571-579 (Pubitemid 38981997)
58. Zenker, M.; Aigner, T.; Wendler, O.; Tralau, T.; Muntefering, H.; Fenski, R.; Pitz, S.; Schumacher, V.; Royer-Pokora, B.; Wuhl, E.; Cochat, P.; Bouvier, R.; Kraus, C.; Mark, K.; Madlon, H.; Dotsch, J.; Rascher, W.; Maruniak-Chudek, I.; Lennert, T.; Neumann, L. M.; Reis, A. Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Hum. Mol. Genet., 2004, 13, 2625-2632 (Pubitemid 39485411)
59. Coppes, M. J.; Huff, V.; Pelletier, J. Denys-Drash syndrome: relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1. J. Pediatr., 1993, 123, 673-678 (Pubitemid 23316416)
60. Ruf, R. G.; Schultheiss, M.; Lichtenberger, A.; Karle, S. M.; Zalewski, I.; Mucha, B.; Everding, A. S.; Neuhaus, T.; Patzer, L.; Plank, C.; Haas, J. P.; Ozaltin, F.; Imm, A.; Fuchshuber, A.; Bak kaloglu, A.; Hildebrandt, F. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int., 2004, 66, 564-570
61. Chin, G.; Luxton, G.; Harvey, J. M. Infliximab and nephrotic syndrome. Nephrol. Dial. Transplant, 2005, 20, 2824-2826
62. Raveh, D.; Shemesh, O.; Ashkenazi, Y. J.; Winkler, R.; Barak, V. Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. Pediatr. Nephrol., 2004, 19, 1281-1284 (Pubitemid 39462432)
63. Toubiana, J.; Schlageter, M. H.; Aoun, B.; Dunand, O.; Vitkevic, R.; Bensman, A.; Ulinski, T. Therapy-resistant anaemia in congenital nephrotic syndrome of the Finnish type - implication of EPO, transferrin and transcobalamin losses. Nephrol. Dial. Transplant, 2009, 24, 1338-1340